Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2025-12-24 @ 2:08 PM
NCT ID:
NCT05997095
Eligibility Criteria:
Inclusion Criteria:
* Aged 60-85 y
* Willing and able to give informed consent for participation in the study
Exclusion Criteria:
* BMI \<18.5 or \>35kg/m2
* Participation in any regular, structured RET within the past 6 months
* Musculoskeletal disorders
* Severe respiratory disease:
* COPD
* Pulmonary hypertension
* Neurological disorders:
* Cerebrovascular disease (cerebral haemorrhage; cerebral ischemic stroke)
* Intracranial space-occupying lesion
* Epilepsy
* Metabolic disease:
* Hyper and hypo parathyroidism
* Untreated hyper and hypothyroidism
* Cushing's disease
* Type 1 or 2 diabetes
* Active cardiovascular problems:
* Uncontrolled hypertension (BP\>160/100mmHg)
* Recent cardiac event
* Heart failure (Class III/IV)
* Arrhythmia
* Angina
* Blood clotting disorders
* Active inflammatory bowel or renal disease
* Recent malignancy (in previous 3 years)
* Recent steroid treatment within 6 months or hormone replacement therapy
* Family history of early (\<55yrs) death from cardiovascular disease
* Known sensitivity to Sonovue
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
85 Years
Study:
NCT05997095
Study Brief:
Protocol Section:
NCT05997095